表紙
市場調査レポート

世界の製薬業界の景況感の分析

Pharmaceutical Industry Business Confidence Report H1 2016

発行 Kable 商品コード 325312
出版日 ページ情報 英文 49 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.95円で換算しております。
Back to Top
世界の製薬業界の景況感の分析 Pharmaceutical Industry Business Confidence Report H1 2016
出版日: 2016年03月01日 ページ情報: 英文 49 Pages
概要

当レポートでは、全世界の製薬業界の主要企業へのアンケート調査の結果を踏まえて、同産業の現在の景況感や今後の見通しについて分析・考察しております。

目次

  • 分析手法と標本サイズ
  • 景気の現状
  • 成長見通しと消費者マインド
  • 供給者価格と支出水準
  • 企業側の将来展望と戦略
  • 調達予算と支出額見通し
  • 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: KG6220PR

Summary

The existing economic environment is stable for the pharmaceutical industry, and customer confidence levels will remain constant in H1 2016 (January 2016-June 2016). Companies are slightly optimistic about economic conditions in North America and Asia-Pacific due to positive momentum in the US manufacturing and production sectors, firm domestic demand, strong government expenditure in India, and robust private consumption and export growth in South Korea and Vietnam. Over the next six months the industry will increase its expenditure towards new product development and IT infrastructure. Moreover, companies operating in Asia-Pacific forecast their budget allocation for pharmaceutical equipment to increase significantly in 2016, compared to 2015.

Key Findings

In total, 43% of pharmaceutical industry business executives expect the global economy to be stable in H1 2016 (January 2016-June 2016). Furthermore, 33% of survey respondents anticipate a favorable or very favorable economic environment

Overall, 83% of respondents who operate in Europe are optimistic over company growth prospects, while no executives anticipate a negative impact on the industry in the region

Business executives operating in the Rest of the World region anticipate the highest increase in staff headcount growth over the next six months

In H1 2016, the majority of business executives from North America are concerned about the performance of North American economies, the performance of the Eurozone, and cyber crime

Survey results reveal that 41% of pharmaceutical industry respondents who operate in Asia-Pacific expect an increase of 1-5% in the budget for pharmaceutical equipment during 2016

Synopsis

Kable's pharmaceutical Industry Business Confidence Survey H1 2016 examines executives' opinion on the business environment over January-June 2016. It also highlights existing economic conditions, supplier price variations, sales performance, industry and company growth outlook, spending patterns, and key priorities. Additionally, the report includes trends in the pharmaceutical equipment market, analysis of the procurement budget allocations, and leading suppliers of pharmaceutical equipment.

What else does this report offer?

Current state of the global economy: examines prevailing economic conditions globally and across various regions

Company and industry growth outlook: provides industry executives' expectations towards the growth prospects of their company and the industry over the next six months

Change in customer confidence: analyzes pharmaceutical industry executives' opinion about the change in customer confidence during H1 2016

Supplier prices projection: determines expected change in supplier prices across various categories and their impact on business confidence

Change in staff headcount and sales performance: tracks expected change in staff headcount and sales for H1 2016 among industry executives globally

Significant investment activities: highlights various areas in which industry executives intend to invest over the next six months

Business concerns: provides information about potential business concerns indicated by survey respondents for H1 2016

Key priorities: identifies the top priorities of industry executives operating in various regions

Purchase preferences: analyzing the purchasing behavior towards pharmaceutical equipment and investment allocations in the pharmaceutical equipment categories

Budget allocation: examining total procurement budget split between capital expenditure and operating expenditure, and tracking the changes in the budget for 2015 and expectations for 2016

Reasons To Buy

Helps organizations to make effective business strategy decisions by knowing the prevailing business conditions and sentiment within the pharmaceutical industry

Organizations will be supported in business expansion decisions by providing information about projected change in sales performance and supplier prices

Helps to improve operational efficiency of the organization by knowing about key priorities and the main concerns of pharmaceutical industry executives

Helps to alter investment allocation by understanding key focus areas highlighted by survey respondents during H1 2016

Enables organizations to make key decisions on purchase preferences and investments in pharmaceutical equipment

Table of Contents

Introduction

  • Definitions
  • Methodology and sample size
  • Respondent profile

Economic State, growth prospects and customer confidence

  • Existing economic environment
  • Industry and company growth outlook
  • Expected change in customer confidence

Supplier prices, staff headcount and sales performance

  • Supplier prices expectations
  • Anticipated change in staff head count and sales projections
  • Anticipated change in spend on key activities

Business concerns and organizational priorities

  • Level of concerns and expected impact
  • Significance of potential business priorities
  • Procurement budget and expenditure outlook
  • Purchase preferences for pharmaceutical equipment
  • Frequency of investments towards various equipment categories

Procurement of number of pieces of equipment

  • Average expenditure per purchase
  • Allocation of investment for equipment purchases
  • Distribution of procurement budget between capital and operating expenditure
  • Change in procurement budget expenditure
  • Variation in pharmaceutical equipment budget from 2015 to 2016
  • Leading suppliers across pharmaceutical equipment types

Appendix

List of Figures

  • Figure 1: Current economic condition - Overall
  • Figure 2: Current economic condition - Region
  • Figure 3: Current economic condition - Those who operate and do not operate in a region
  • Figure 4: Industry and company growth prospects - Overall
  • Figure 5: Industry and company growth prospects - Overall - In detail
  • Figure 6: Industry and company growth prospects - Region
  • Figure 7: Anticipated variation in customer confidence - Overall
  • Figure 8: Anticipated variation in customer confidence - Region
  • Figure 9: Projected change in supplier prices - Raw Materials - Overall and regional
  • Figure 10: Projected change in supplier prices - Semi-finished products - Overall and regional
  • Figure 11: Projected change in supplier prices - Packaging - Overall and regional
  • Figure 12: Projected change in supplier prices - Ingredients - Overall and regional
  • Figure 13: Staff headcount and sales outlook - Regional
  • Figure 14: Expenditure projection on key activities - Overall
  • Figure 15: Top five business concerns - Region
  • Figure 16: Business concerns - Overall and regional
  • Figure 17: Business concerns - Overall and regional
  • Figure 18: Top five organizational priorities - Region
  • Figure 19: Organizational priorities - Overall and region
  • Figure 20: Purchase preferences - Region
  • Figure 21: Frequency of investments - Overall
  • Figure 22: Procurement of number of pieces of equipment - Overall
  • Figure 23: Average expenditure per purchase - Overall
  • Figure 24: Investment allocation for equipment purchases - Region
  • Figure 25: Distribution of procurement budget - Region
  • Figure 26: Change in procurement budget expenditure - Region
  • Figure 27: Change in pharmaceutical equipment budget - Region
  • Figure 28: Leading suppliers across pharmaceutical equipment types - Overall
Back to Top